Post Type Archives: News

Astoriom, a global quality expert in safeguarding scientific research and consumer product sample assets, today announced the appointment of Will Edwards as Chief Executive Officer. Will will continue to build on Astoriom’s strong foundations to support the next phase of growth across its international portfolio of sample stability storage, biorepository services, validation solutions, as well […]

Optibrium, a leading developer of software and AI solutions for molecular design, today announced the appointment of Dr Nathan Brown as Director of Science, strengthening the company’s position in delivering scientifically rigorous software that addresses real-world efficiency and productivity challenges in molecular discovery. Nathan will lead the Research and Application Science teams in this new […]

Milestone marks progress against AbbVie’s previously announced commitment to invest more than $10 billion of capital in the U.S. over the next decade to broadly support innovation and expand critical manufacturing capabilities and capacity Supports production of AbbVie’s current and next-generation immunology and neuroscience medicines Transaction anticipated to close in mid-2026 AbbVie and West Pharmaceutical Services announced […]

Bio‑Sourcing and Zerion Pharma A/S announced that their joint project to develop an oral formulation of Trastuzumab, the pioneer monoclonal antibody used to treat breast cancer, has been awarded funding under EUREKA Eurostars. This is Bio‑Sourcing’s second Eurostars success and, together with Zerion’s breakthrough Dispersome® technology, it will support the development of an oral formulation […]

Hongene Biotech today announced the receipt of a grant from the Gates Foundation to develop high-quality, affordable, and patent-free cap analogs for use in mRNA vaccine production. With this grant, Hongene aims to strengthen global vaccine supply chains and ensure equitable access for low- and middle-income countries (LMICs). As part of this initiative, Hongene will […]

Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating from five sites across India and Europe, – announced the opening of a new discovery and preclinical facility at Noida [Delhi NCR], doubling its overall chemistry capacity for discovery research and scale-up projects. The multimillion-dollar facility combines discovery and early-phase scale-up […]

Aragen launches CHOMax™, a new cell line development and early manufacturing platform that supports an integrated path from DNA to IND-enabling clinical supply in ~10 months* for suitable standard IgG monoclonal antibodies. This accelerated, royalty-free approach provides biotech and pharma partners with a clearly structured development pathway, including both drug substance and drug product support. […]

Codexis, Inc., a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Group, an oligonucleotide Contract Research Development and Manufacturing organization (CRDMO), today announced that they have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis Manufacturing Platform. This partnership provides Axolabs access to an […]

Shilpa Medicare Limited announces its intention to pursue a US approval within the next two years and is actively seeking licensing partners for its Ondansetron Extended-Release Injection (OERIS™), following the successful completion of a Phase 3 study in India that met all primary and secondary endpoints. OERIS™ is a novel extended-release antiemetic [5-HT3 receptor antagonist] […]

Eli Lilly and InduPro, a biotechnology company specializing in inherent and induced proximity biology, announced a strategic collaboration and licensing agreement on January 7th, 2026. InduPro will use its proximity-guided platform to assist Lilly in the discovery and development of up to three targets for novel oncology treatments. Per the terms of the agreement, Lilly […]